Neuronal ceroid lipofuscinosis

Gene: CLCN6

Green List (high evidence)

CLCN6 (chloride voltage-gated channel 6)
EnsemblGeneIds (GRCh38): ENSG00000011021
EnsemblGeneIds (GRCh37): ENSG00000011021
OMIM: 602726, Gene2Phenotype
CLCN6 is in 5 panels

4 reviews

Achchuthan Shanmugasundram (Genomics England Curator)

Green List (high evidence)

The rating of this gene has been updated to Green following NHS Genomic Medicine Service approval.
Created: 1 Feb 2023, 11:30 a.m. | Last Modified: 1 Feb 2023, 11:30 a.m.
Panel Version: 1.27

Sarah Leigh (Genomics England Curator)

I don't know

Comment on mode of pathogenicity: PMID 33217309 reports gain of function associated with CLCN6 variants.
Created: 8 Jan 2024, 2:54 p.m. | Last Modified: 8 Jan 2024, 2:54 p.m.
Panel Version: 2.5
PMIDs: 16950870 & 21107136 report the characterization of CLCN6 deficient mouse model, which display some features of neuronal ceroid lipofuscinosis. PMID: 16950870 identifies two heterozygous CLCN6 variants (p.V580M, p.T628R) in 2/75 patients with late-onset neuronal ceroid lipofuscinosis, however, the authors concluded that there was insufficient evidence for these variants being responsible for the phenotype in the patients.
Created: 27 Jun 2023, 11:53 a.m. | Last Modified: 27 Jun 2023, 11:53 a.m.
Panel Version: 2.2
Associated with relevant phenotype in OMIM and as confirmed Gen2Phen gene. At least three de novo occurrances of a single variant reported.
Created: 17 Mar 2021, 6:31 p.m. | Last Modified: 17 Mar 2021, 6:31 p.m.
Panel Version: 1.23
Comment on list classification: There is enough evidence for this gene to be rated GREEN at the next major review.
Created: 17 Mar 2021, 6:27 p.m. | Last Modified: 17 Mar 2021, 6:27 p.m.
Panel Version: 1.23
Comment on phenotypes: There is no Mondo term for this phenotype at present
Created: 17 Mar 2021, 6:24 p.m. | Last Modified: 17 Mar 2021, 6:24 p.m.
Panel Version: 1.21

Publications

Zornitza Stark (Australian Genomics)

Green List (high evidence)

PMID 33217309: Three unrelated families reported with recurrent GOF de novo c.1658A>G (p.Tyr553Cys) and severe developmental delay with pronounced generalized hypotonia, respiratory insufficiency, and variable neurodegeneration and diffusion restriction in cerebral peduncles, midbrain, and/or brainstem in MRI scans.

Previously, monoallelic variants reported in 3 families with BPEI, but functional data/segregation not compelling.

Mouse knockout model has features of NCL.
Created: 9 Dec 2020, 8:08 a.m. | Last Modified: 9 Dec 2020, 8:08 a.m.
Panel Version: 1.4

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Neurodegeneration; Benign partial epilepsy; febrile seizures; NCL

Publications

Emma Ashton (Great Ormond Street Hospital)

Red List (low evidence)

Mode of inheritance
Unknown

Variants in this GENE are reported as part of current diagnostic practice

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
Sources
  • Expert Review Green
  • NHS GMS
  • London North GLH
Phenotypes
  • Neurodegeneration, childhood-onset, hypotonia, respiratory insufficiency and brain imaging abnormalities OMIM:619173
OMIM
602726
Clinvar variants
Variants in CLCN6
Penetrance
None
Publications
Mode of Pathogenicity
Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments
Panels with this gene

History Filter Activity

8 Jan 2024, Gel status: 3

Set mode of pathogenicity

Sarah Leigh (Genomics England Curator)

Mode of pathogenicity for gene: CLCN6 was changed from None to Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments

8 Jan 2024, Gel status: 3

Set mode of pathogenicity

Sarah Leigh (Genomics England Curator)

Mode of pathogenicity for gene: CLCN6 was changed from to None

27 Jun 2023, Gel status: 3

Set publications

Sarah Leigh (Genomics England Curator)

Publications for gene: CLCN6 were set to 29667327; 26658788; 25794116; 21107136; 33217309

1 Feb 2023, Gel status: 3

Removed Tag

Achchuthan Shanmugasundram (Genomics England Curator)

Tag Q2_21_rating was removed from gene: CLCN6.

1 Feb 2023, Gel status: 3

Added New Source, Status Update

Achchuthan Shanmugasundram (Genomics England Curator)

Source Expert Review Green was added to CLCN6. Rating Changed from Amber List (moderate evidence) to Green List (high evidence)

17 Mar 2021, Gel status: 2

Added Tag

Sarah Leigh (Genomics England Curator)

Tag Q2_21_rating tag was added to gene: CLCN6.

17 Mar 2021, Gel status: 2

Entity classified by Genomics England curator

Sarah Leigh (Genomics England Curator)

Gene: clcn6 has been classified as Amber List (Moderate Evidence).

17 Mar 2021, Gel status: 1

Set mode of inheritance

Sarah Leigh (Genomics England Curator)

Mode of inheritance for gene: CLCN6 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

17 Mar 2021, Gel status: 1

Set Phenotypes

Sarah Leigh (Genomics England Curator)

Phenotypes for gene: CLCN6 were changed from to Neurodegeneration, childhood-onset, hypotonia, respiratory insufficiency and brain imaging abnormalities OMIM:619173

17 Mar 2021, Gel status: 1

Set publications

Sarah Leigh (Genomics England Curator)

Publications for gene: CLCN6 were set to 29667327; 26658788; 25794116

9 Jul 2019, Gel status: 1

Set publications

Sarah Leigh (Genomics England Curator)

Publications for gene: CLCN6 were set to

13 Feb 2019, Gel status: 1

Created, Added New Source, Set mode of inheritance

Ivone Leong (Genomics England Curator)

gene: CLCN6 was added gene: CLCN6 was added to Neuronal ceroid lipofuscinosis. Sources: London North GLH,NHS GMS,Expert Review Red Mode of inheritance for gene: CLCN6 was set to Unknown